Sihuan Pharma Unwinds Investment from Firm Started by Son of China’s Premier

New Horizon Capital has sold its 540 million RMB ($80 million) investment in Sihuan Pharma Holdings back to the company, after the Hong Kong exchange objected to the original transaction. New Horizon, a private equity firm, was co-founded by Wen Yunsong, the son of China's Premier. New Horizon accepted a gain of “only” 60%. Regulators felt the purchase, made just three months before Sihuan’s planned IPO, looked like New Horizon was given a sweetheart price. More details.... Stock Symbol: (HK: 0460)